Sign In

The AASLD Liver Meeting 2017, Washington DC, October 20-24

21st Century Hepatology: Translating Discoveries into Practice


  • Saturday, October 21, 8 am–5:15 pm

Program Chairs

  • Ronald J. Sokol, MD, FAASLD
  • K. Rajender Reddy, MD, FAASLD
  • Mary E. Rinella, MD, FAASLD

Continuing Education Information

  • CME – 6.75 AMA PRA Category 1 Credits™
  • MOC - 6.75 Hours
  • CE - 6.75 Hours

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Understand evidence-based evaluation and management options available for a spectrum of liver problems and the benefits and risks of each approach.
  • Be better informed to make rational decisions for optimal management of patients and engage patients in shared-decision making.
  • Incorporate new emerging knowledge and evidence into practice of hepatology.

Session Description/Needs Statement

Emphasize current state-of-the-art evaluation and management of liver disease, based on new and best evidence and mentioning therapeutic advances or those on the horizon; understand the application of biomarkers, genetics, lifestyle and other evidence to guide personalized therapy where relevant.

Session I: Hepatitis Module

Moderators: Norah Terrault MD, MPH, FAASLD and Raymond T. Chung MD, FAASLD

  • 8-8:05 am
    Welcome and Introduction
    Ronald J. Sokol MD, FAASLD
  • 8:05-8:25 am
    Autoimmune Hepatitis – New Pathways and Therapeutic Strategies
    Michael P. Manns, MD
  • 8:25-8:45 am
    Innovative Strategies To Cure and Eradicate Hepatitis B in the 21st Century
    Marc G. Ghany, MD, FAASLD
  • 8:45-9:05 am
    Hepatitis C: Can We Translate A Cure into Real-world Practice?
    David R. Nelson, MD

Session II: Steatohepatitis Module

Moderators: Mary E. Rinella, MD, FAASLD and Vijay  Shah, MD

  • 9:05-9:25 am
    Role of Gut-liver Axis in Obesity and Fatty Liver
    Jasmohan S. Bajaj, MD, FAASLD
  • 9:25-9:45 am
    Enduring Role of Liver Biopsy in Diagnosis and Assessment of Therapeutic Response
    David Kleiner, MD, PhD
  • 9:45-10:05 am
    NASH – Imaging and Serum Biomarkers in Treatment Decisions in NASH
    Rohit Loomba, MD
  • 10:05-10:25 am
    NASH – Current and Emerging Therapies
    Quentin M. Anstee, MBBS, PhD
  • 10:25- 10:45 am
    Alcoholic Liver Disease: Confronting an Old Foe with New Treatments
    Gyongyi Szabo, MD, PhD, FAASLD
  • 10:45-11:10 am

Session III: Liver and Biliary Cancer Module

Moderators: Julie Heimbach, MD and Elizabeth M. Brunt, MD, FAASLD

  • 11:10-11:30 am
    Screening for Hepatobiliary Neoplasia – Where are We Now?
    Hashem B. El-Serag, MD, MPH
  • 11:30-11:50 am
    Advances in the Diagnosis of Hepatobiliary Neoplasia
    Jorge A. Marrero, MD
  • 11:50 am-12:10 pm
    Individualizing Treatment in Hepatobiliary Neoplasia
    Laura M. Kulik, MD
  • 12:10 -12:30 pm
    Evolving Role of Liver Transplantation in Hepatobiliary Neoplasia
    Francis Yao, MD
  • 12:30-2:00 pm
    Intermission – Meet-the-Professor Luncheons (Clinical)
    *Ticketed Session

Session IV: Cholestatic, Genetic and Drug-induced Liver Diseases Module

Moderators: Michael H. Trauner, MD, FAASLD and Cara L. Mack, MD

  • 2:00-2:20 pm
    Therapeutic Advances in Adult Cholestatic Liver Diseases
    Cynthia Levy, MD, FAASLD
  • 2:20-2:40 pm
    Pediatric Cholestatic Liver Diseases: Advances in Diagnosis and Management
    Jorge A. Bezerra, MD, FAASLD
  • 2:40-3:00 pm
    Drug-induced Liver Diseases – Paradigms for Identification and Management
    Guruprasad P. Aithal, MD, PhD
  • 3:00-3:30 pm

Session V: Challenges in Advanced Liver Disease Management

Moderators: Lopa  Mishra, MD, FAASLD and K. Rajender  Reddy, MD, FAASLD

  • 3:30-3:50 pm
    Optimizing Outcomes in the Deconditioned Cirrhotic
    Jennifer C. Lai, MD
  • 3:50-4:10 pm
    Diagnosis and Management of Kidney Injury: From Urinalysis to Proteomics
    Paolo Angeli, MD, PhD
  • 4:10-4:30 pm
    Coagulation Derangements in Cirrhosis – A New Paradigm
    R. Todd Stravitz, MD, FAASLD
  • 4:30-4:50 pm
    Bridging Acute or Acute-on-Chronic Liver Failure Patient to Transplant
    Jacqueline G. O’Leary, MD, MPH
  • 4:50-5:10 pm
    New Strategies for Managing Portal Hypertension and its Manifestations
    Guadalupe Garcia-Tsao, MD, FAASLD
  • 5:10-5:15 pm
    Wrap Up
    Ronald J. Sokol, MD, FAASLD